Brief: Interpace Biosciences - Jack Stover To Retire As President And CEO, Thomas Burnell Appointed As Successor
Nov 25 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES ANNOUNCES EXECUTIVE TRANSITION: JACK
STOVER TO RETIRE AS PRESIDENT AND CHIEF EXECUTIVE OFFICER THOMAS
BURNELL APPOINTED AS SUCCESSOR
* INTERPACE BIOSCIENCES INC - STOVER WILL SERVE AS AN
ADVISOR TO
COMPANY THROUGH MIDDLE OF 2021 IN ORDER TO SUPPORT TRANSITION
Source text for Eikon: ID:nGNXYBtDH
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million